The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: Correlation between plasma HIV-1 RNA and proinflammatory cytokine levels

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 807-810

  Dezube, Bruce J ^a   Lederman, Michael M ^b   Chapman, Beryl ^b   Georges, Daniel L ^b   Dogon, Alex L ^b   Mudido, Phillipa ^b   Reis Lishing, Joann ^b   Cheng, Shu Lin ^b   Silberman, Sandra L ^b   Crumpacker, Clyde S ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIGEN P24; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PLACEBO; TENIDAP; TUMOR NECROSIS FACTOR; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS;

EID: 16944363271     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517308     Document Type: Article

References (15)

1. Madhok R. Tenidap. Lancet 1995;346:481-5.
2. Sipe JD, Battle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. J Immunol 1992;148:480-4.
3. Littman BH, Drury CE, Zimmerer RO, Stack CB, Law CG. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap. Arthritis Rheum 1995;38:29-37.
4. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated 1L-6 levels and production. J Immunol 1990;144:480-4.
5. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-8.
6. Kirby DS, Loose LD, Weiner ES, Wilhem FE, Shanahan WR, Ting N. Tenidap vs naproxen treatment of rheumatoid arthritis. Arthritis Rheum 1993;36:S112.
7. Kraska AR, Wilhelm FE, Kirby DS, et al. Tenidap vs piroxicam vs piroxicam plus hydroxychloroquine in rheumatoid arthritis. Arthritis Rheum 1993;36:S57.
8. Dezube BJ, Ahlers CM, Lawrence JP, et al. Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:13-7.
9. McNiff PL, Svensson L, Pazoles CJ, Gabel CA. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro: mechanism and evidence of functional significance. J Immunol 1994;153:2180-93.
10. Proudman KE, McMillan RM. Are tolfenamic acid and tenidap dual inhibitors of 5-lipooxygenase and cyclo-oxygenase? Agents Actions 1991;34:121-4.
11. Dezube BJ. Pentoxifylline for the treatment of infection with human immunodeficiency virus. Clin Infect Dis 1994;18:285-7.
12. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988;263:5380-4.
13. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86:5974-8.
14. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
15. Coopman SA, Johnson RA, Platt R, Stem RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670-4.